Swedish Exchange Growth Companies With Minimum 28% Insider Ownership
In This Article:
As global markets show signs of resilience, with indices like the S&P 500 reaching new highs, investors are keenly observing trends and shifts across various regions. In Sweden, growth companies with high insider ownership are garnering attention as potentially stable investments in a fluctuating economic landscape.
Top 10 Growth Companies With High Insider Ownership In Sweden
| Name | Insider Ownership | Earnings Growth |
| CTT Systems (OM:CTT) | 16.9% | 21.6% |
| BioArctic (OM:BIOA B) | 35.1% | 50.9% |
| Sileon (OM:SILEON) | 33.3% | 109.3% |
| KebNi (OM:KEBNI B) | 37.8% | 90.4% |
| edyoutec (NGM:EDYOU) | 14.6% | 63.1% |
| Biovica International (OM:BIOVIC B) | 12.7% | 73.8% |
| Calliditas Therapeutics (OM:CALTX) | 11.6% | 52.9% |
| Egetis Therapeutics (OM:EGTX) | 17.6% | 98.2% |
| Yubico (OM:YUBICO) | 37.5% | 43.4% |
| SaveLend Group (OM:YIELD) | 24.9% | 103.4% |
Here we highlight a subset of our preferred stocks from the screener.
BioArctic
Simply Wall St Growth Rating: ★★★★★★
Overview: BioArctic AB (publ) focuses on developing biological drugs for central nervous system disorders in Sweden, with a market capitalization of SEK 19.70 billion.
Operations: The company generates SEK 252.21 million in revenue from its biotechnology segment.
Insider Ownership: 35.1%
BioArctic, a Swedish biopharmaceutical company, recently gained approval in South Korea for Leqembi?, marking significant progress in Alzheimer's treatment. Despite a challenging Q1 with revenues down to SEK 29.64 million from SEK 393.43 million and a shift from profit to a loss of SEK 57.56 million, analysts remain optimistic about its potential growth. The stock is currently seen as undervalued, trading 67.1% below its estimated fair value with expectations of substantial revenue growth (40.8% per year) and profitability within three years. Additionally, insider transactions have not shown significant buying activity recently.
-
Get an in-depth perspective on BioArctic's performance by reading our analyst estimates report here.
-
The valuation report we've compiled suggests that BioArctic's current price could be quite moderate.
AB Sagax
Simply Wall St Growth Rating: ★★★★☆☆
Overview: AB Sagax (publ) is a property company active in Sweden, Finland, France, Benelux, Spain, Germany, and other European regions with a market capitalization of approximately SEK 93.07 billion.
Operations: The company generates its revenue primarily through real estate rentals, amounting to SEK 4.47 billion.
Insider Ownership: 28.3%
AB Sagax, a Swedish company, has shown robust growth with a 53.3% increase in earnings over the past year. Despite shareholder dilution and debt not well covered by operating cash flow, earnings are forecasted to grow at 33.4% annually, outpacing the Swedish market's 13.9%. Recent financial activities include issuing €500 million in green bonds to support corporate initiatives under its Green Finance Framework and approving dividends for its shareholders, reflecting confidence in ongoing financial health and commitment to growth.